Article Details
Retrieved on: 2024-06-12 23:02:32
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Nature Communications published the results of a study on ARCT-154, CSL's sa-mRNA COVID-19 vaccine. The study showed that it is well-tolerated, ...
Article found on: www.infectioncontroltoday.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here